| Name | Title | Contact Details |
|---|---|---|
Gina Di Domenico |
Associate Deputy City Attorney | Profile |
ECIJA, with more than 25 years of experience, is in the Top 10 of the best firms in Spain, according to the prestigious rankings of Chambers & Partners and The Legal 500 and has established itself in the first place as a full service law firm. It has been recognised by The Lawyer as the best TMT firm in Europe and by the Financial Times as the most innovative firm on continental Europe. Its relevance in the Spanish market has been recognised by Expansión and Forbes, which have recognised it as the best firm in Digital Economy in Spain. ECIJA has a team of more than 200 partners and 1000 professionals globally, distributed in countries such as Spain, Portugal, Colombia, Chile, Honduras, Costa Rica, Dominican Republic, Nicaragua, Guatemala, El Salvador, Puerto Rico, Panama, Mexico, Brazil, Ecuador, Argentina and Uruguay. ECIJA is a full-service firm, with core practices in Corporate, M&A, Commercial and TMT, and large labor, litigation and tax groups. The Firm has offices in Spain, Portugal, USA, Central & Latin America and collaborates in all EU and worldwide jurisdictions. The Firm started in the year 1997 and has grown since then to become a full service Firm with presence in all areas of law and sectors. Our Legal Services include: Private Corporate Law, including: -Mergers and Acquisitions (M&A) -Private Equity and Venture Capital -General Corporate Law -Banking Law -Capital Markets -Competition Law and European Law -Human Resources & Employment Benefits -IT, Media, Data Protection and IP Law -Litigation and Arbitration -Project Finance -Public Law -Real Estate and Planning Law -Risk & Compliance -Tax To discuss how ECIJA attorneys can assist you and your business, please visit our website (www.ecija.com)
TowMate is a company based out of Rogers, Arkansas that has been manufacturing wireless tow lights and other safety lighting for automotive and marine applications for over 35 years. Manufactured in the USA and backed by a Lifetime Warranty on electronics and LEDs, TowMate is second to none in quality and service after the sale. Additional products include LED strobes, overhead light bars, the Life Saver cone mounted warning light system, and the Safety Alert System roadside perimeter warning system.
"Love of invention will never end." - Carl Benz Learn more about us as we continue to pioneer the future of driving excellence. Data privacy: mb4.me/provider_privacy Imprint: Mercedes-Benz AG Mercedesstraße 120 D-70372 Stuttgart Deutschland Tel.: +49 7 11 17-0 E-Mail: dialog.mb@mercedes-benz.com Vertreten durch den Vorstand: Ola Källenius (Vorsitzender), Jörg Burzer, Renata Jungo Brüngger, Sabine Kohleisen, Harald Wilhelm, Markus Schäfer, Britta Seeger Vorsitzender des Aufsichtsrats: Martin Brudermüller Handelsregister beim Amtsgericht Stuttgart, Nr. HRB 762873 Umsatzsteueridentifikationsnummer: DE321281763
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
In 2015, an important group of investors alongside a group of experienced professionals in the Reinsurance industry, acquired a majority interest in MBI Americas. Now, XS Global, a well-known regional MGA and Coverholder at Lloyds. The groups footprint and ambitions now encompass the underwriting space, utilizing strong synergies that exist between the groups core business strategy. Our unique structure provides us opportunities to deploy targeted reinsurance capacity both directly to corporates and to retail brokers via expert and locally based underwriters. We are proud to say we invest in talent and our team has proven skills, excellent access, and a proven track record for underwriting profitable business in the Latin America region and beyond.